Weld, E.D., Beattie, T., Moodley, J., Mapendere, M., Salles, I., Solans, B.P., Nonyane, B.A., Wiesner, L., Nielson, T., Edward, V.A. and Chihota, V., 2025. Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial. The Lancet HIV.
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial
- Journal Articles
